Endocrine Abstracts

Adrenal tumors are common, diagnosed in around 5% of adults undergoing abdominal cross-sectional imaging. When evaluated by endocrinologists, adrenal adenomas are diagnosed in 85% of patients with adrenal tumors, other benign tumors, such as myelolipomas or cysts, in 3-6%, pheochromocytomas in 2-4%, adrenal carcinomas in 4-6%, and other malignant tumors in 1-3%. Imaging and hormonal assessments are key in determining the etiology of adrenal mass, though a thorough review of clinical presentation, medical history, and genetics can aid the diagnosis. Recent 2023 guidelines on adrenal incidentalomas recommend a multidisciplinary tumor board (MDT) review of any patients with indeterminate adrenal tumors. In addition, rare and unusual presentations benefit from the MDT review. In this presentation, we will review presentation, management, and outcomes of several rare, unusual, or thought-provoking clinical cases reviewed and discussed at MDT.